Abal, Abal S.
HRN: 23-30-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/10/2023
07/16/2023
IVTT
600mg
Q8
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes